Pfizer Teams Up With Microfinanciers In China, Nobel Peace Prize Laureates In Bangladesh, To Help Narrow Health Gap Between World’s Rich And Poor
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Figuring out how to extend basic healthcare and access to essential medicines to the two-thirds of humanity who eke out an existence on less than $10 a day has long puzzled philanthropists, politicians and even Nobel Peace Prize winners
You may also be interested in...
What's The Winning Strategy In China? Franchises Are Key
Despite increasing concerns over protectionist policies in China, Morgan Stanley believes that market-based choices will trump government policies during the next decade, leading to success for multinational companies over the long term in the world's fastest-growing market
What's The Winning Strategy In China? Franchises Are Key
Despite increasing concerns over protectionist policies in China, Morgan Stanley believes that market-based choices will trump government policies during the next decade, leading to success for multinational companies over the long term in the world's fastest-growing market
Players That Evolve In Tandem With China's Health System Reforms Will Survive and Prosper, Says Pfizer Executive
Pfizer and French micro-credit group are exploring new approaches to help poor in China access medical care and medicines; Pfizer also testing micro-finance programs in India to help build rural health clinics.